This database provides information on environmentally related taxes, fees and charges, tradable permit systems, deposit refund systems, environmentally motivated subsidies and voluntary approaches used in environmental policy in OECD member countries and a number of other countries. Developed in co-operation between the OECD and the European Environment Agency.
Those in-depth studies of the health system of member countries focus on economic issues. They assess the performance of health systems in a comparative context, identify the main challenges faced by the country health system and put forward policy options to better meet them. Reviews are initiated at the request of the country to be examined and emphasis is placed on specific issues of key policy interest.
English, PDF, 183kb
Agricultural research fellowship award grants and international conferences sponsorships of the Co-operative Research Programme (CRP): Biological Resource Management for Sustainable Agricultural Systems; advice for applicants for funding.
English, PDF, 106kb
The tax burden in Switzerland declined by 0.3 percentage points from 26.9% to 26.6% in 2014. The corresponding figures for the OECD average were an increase of 0.2 percentage points from 34.2% to 34.4%.
Switzerland’s recent economic performance has been impressive, but with growth now slowing new reforms will be necessary to maintain high levels of prosperity and ensure future well-being, according to the latest OECD Economic Survey of Switzerland.
The 2015 edition introduces more detailed analysis of participation in early childhood and tertiary levels of education. The report also examines first generation tertiary-educated adults’ educational and social mobility, labour market outcomes for recent graduates, and participation in employer-sponsored formal and/or non-formal education.
English, PDF, 86kb
Die Gesundheitsausgaben in der Schweiz sind hoch und der Ausgabenanstieg hat sich in den letzten Jahren beschleunigt. Der Marktanteil von Generika in der Schweiz ist relativ gering; die verstärkte Förderung bei Verschreibung und Abgabe von Generika könnte den Anstieg bei den Arzneimittelausgaben verlangsamen.
English, PDF, 1,739kb
This note presents selected findings based on the set of well-being indicators published in How's Life? 2015.
In 2014, Switzerland provided USD 3.5 billion in net ODA (preliminary data), which represented 0.49% of gross national income (GNI) and a 9.2% increase in real terms from 2013. Switzerland is the 8th largest Development Assistance Committee (DAC) donor in terms of ODA as a percentage of GNI, and the 11th donor by volume.